Clinical Trials Logo

Alzheimer Disease clinical trials

View clinical trials related to Alzheimer Disease.

Filter by:

NCT ID: NCT04901494 Withdrawn - Alzheimer Disease Clinical Trials

SSRI's and the Rate of Progression From MCI to Dementia

Start date: September 1, 2021
Phase:
Study type: Observational

This trial is investigating if serotonin reuptake inhibitor (SSRI) use in Mild Cognitive Impairment (MCI) patients will lead to a lower rate of progression to dementia. It's hypothesized that patients treated with an SSRI at the time of MCI diagnosis, without evidence of an active primary psychiatric condition other than neurocognitive disorder, will have a lower rate of progression to Alzheimer's disease dementia or to other types of dementia.

NCT ID: NCT04812769 Withdrawn - Dementia Clinical Trials

Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases

eCARE-ID
Start date: April 30, 2022
Phase: N/A
Study type: Interventional

Pilot study to evaluate the feasibility of a pilot embedded pragmatic cluster randomized controlled trial to reduce the duration of antibiotic therapy and number of antibiotic prescriptions in nursing home residents with AD/ADRD.

NCT ID: NCT04514328 Withdrawn - Alzheimer Disease Clinical Trials

Highlighting the Benefits of Therapeutic Gardens in Alzheimer's Disease by 18F-FDG Cerebral PET /CT

JAZTEP
Start date: August 2, 2022
Phase: N/A
Study type: Interventional

The Alzheimer's Plan 2008-2012 allowed the installation of therapeutic gardens for the structures welcoming patients with Alzheimer's disease (AD) . The physical, psychological and social benefits are the improvement of the state of health and overall well-being. There is a positive role in social interactions for patients with AD who can walk in the therapeutic gardens. Indeed, this promotes meetings with caregives and other people. Using the garden decreases the stress level in patients (Ulrich). The therapeutic garden named "art, memory and life" in NANCY is based on art, nature and regional culture. This garden can break with the "artificial" framework of care services often perceived as stressful. In the garden, people walk around and have an experience that could improve self-image perception. A clinical study with 2 groups of AD patients hospitalized in UCC or Cognitive Behavioral Unit took place in Nancy. The evaluation of the QCS (questionnaire on self-awareness) was carried out at the beginning and at the end of the study, - a group of patients went into the garden: the QCS score increased - a group of patients did not go to the garden (they remained in UCC): the QCS score decreased

NCT ID: NCT04440891 Withdrawn - Alzheimer Disease Clinical Trials

Application of TMS Coupled With VR for Slowing the Rate of Cognitive Decline in Patients With Alzheimer's Disease

TMS_AD
Start date: October 3, 2019
Phase: N/A
Study type: Interventional

This is a randomized sham control study to evaluate how repetitive Transcranial Magnetic Stimulation (rTMS), interactive cognitive training, or the combination of rTMS and cognitive training reduce the cognitive decline of patients diagnosed with Alzheimer's disease

NCT ID: NCT04353947 Withdrawn - Parkinson's Disease Clinical Trials

Induction and Recognition of Emotions

IRE
Start date: March 2, 2020
Phase:
Study type: Observational

This study evaluates the differences in cognitive function between healthy older adults, older adults with mild Alzheimer's type dementia and older adults with Parkinson's disease and if there are differences in valence assessment and activation that produce them a mood induction task. Subjects are assessed using neuropsychological tests and then a mood induction task based on movie clips is applied.

NCT ID: NCT04311281 Withdrawn - Clinical trials for Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES)

FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD

FDDNP
Start date: May 2021
Phase:
Study type: Observational

The primary objective of this study is to demonstrate the safety and efficacy of positron emission tomography (PET) imaging with a radioactive compound called [F-18]FDDNP in subjects with suspected Alzheimer's disease or suspected chronic traumatic encephalopathy (CTE) to predict clinical decline after one and two years.

NCT ID: NCT04282798 Withdrawn - Alzheimer Disease Clinical Trials

Racial Variation in Response to Music Interventions for People With Alzheimer's Dementia

Start date: June 2020
Phase: N/A
Study type: Interventional

This project will study the efficacy of a personalized receptive music intervention on neuropsychiatric symptoms and general cognitive function in patients with mild and moderate Alzheimer's disease (AD) by race.

NCT ID: NCT04263519 Withdrawn - Alzheimer Disease Clinical Trials

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

A Pilot open labeled study of Tacrolimus in Alzheimer's Disease.

NCT ID: NCT04255329 Withdrawn - Alzheimer Disease Clinical Trials

Non Verbal Communication and Dementia

GEMAN
Start date: February 2020
Phase: N/A
Study type: Interventional

Cognitive impairements in Alzheimer's and apparented disorders may lead to the decreased engagement in activities, spetially in moderate and advanced stages of evolution. The lack of stimulation for people with dementia is associated with the risk of challenging behaviors, depressives symptoms, sleeping disorders or faster cognitive deterioration. Those challenges may lead to the increased administration of pharmacological treatments, though the risks of neurleptics use in this population are currently known. In this context, non-pharacological interventions hold a significant place in dementia care. This research focuses on cognitve stimulation activities. More precisly, our study compares two aproaches using the reading groups. The first type (" usual " reading group) is based on the principle of stimulating those cognitive functions which dicreases with the evolution of dementia. The second (Montessori reading group) approach relies on the idea to use preserved capacities in order to compensate the cognitive impariments. The aim of our study is to compare the impact of these two non-pharmalogical interventions on non-verbal communication. The collected datas will help analyzing and understanding the internal and behavioral states of people living with dementia. Our study will also extend relfexions about cognitive stimulation groups in care institutions.

NCT ID: NCT04228666 Withdrawn - Alzheimer Disease Clinical Trials

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Start date: March 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment for Alzheimer's disease (AD). The study purpose is to evaluate the safety profile of four IV infusions of HB-adMSCs in subjects with clinical diagnosis of AD.